Drug resistance in leishmaniasis

by Croft SL, Sundar S, Fairlamb AH. Clin Microbiol Rev, January 2006, 19(1):111-26.

Summary: Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is caused by over 15 different species of the protozoan parasite genus Leishmania. It is essential that there be a strategy to prevent the emergence of resistance to new drugs; combination therapy, monitoring of therapy, and improved diagnostics could play an essential role in this strategy.

Click here to download the full article [PDF]